Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9J D Jonkman-de Vries, H Talsma, R E Henrar, et al.Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.Investigational New Drugs|January 1, 1994
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)J D Jonkman-de Vries, M J de Graaff-Teulen, R E Henrar, et al.PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidineB Nuijen, M Bouma, R E Henrar, et al.Journal of Mass Spectrometry : JMS|December 3, 1998
Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryH Rosing, M J Hillebrand, J M Jimeno, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I studyO van Tellingen, C J Punt, A Awada, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|August 1, 1998
Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extractionH Rosing, M J Hillebrand, J M Jimeno, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical modelsH R Hendriks, P E Pizao, D P Berger, et al.PDA Journal of Pharmaceutical Science and Technology|March 1, 1997
Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenurJ D Jonkman-de Vries, B J Van den Bemt, W W ten Bokkel-Huinink, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 1999
Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazoleR W Sparidans, J J Kettenes-van den Bosch, O van Tellingen, et al.Pageof 3